Marine Lefevre
Overview
Explore the profile of Marine Lefevre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Decaudin D, Nemati F, Planchon J, Seguin-Givelet A, Lefevre M, Etienne V, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199558
The combination of chemotherapy and targeted therapy has been validated in non-small-cell lung cancer (NSCLC) patients with mutations. We therefore investigated whether this type of combined approach could be more...
2.
Bonnin E, Rodrigo Riestra M, Marziali F, Mena Osuna R, Denizeau J, Maurin M, et al.
Nat Commun
. 2024 May;
15(1):3749.
PMID: 38702311
Regulatory T cells (Tregs) are plastic cells playing a pivotal role in the maintenance of immune homeostasis. Tregs actively adapt to the microenvironment where they reside; as a consequence, their...
3.
Merlotti A, Sadacca B, Arribas Y, Ngoma M, Burbage M, Goudot C, et al.
Sci Immunol
. 2023 Feb;
8(80):eabm6359.
PMID: 36735774
Although most characterized tumor antigens are encoded by canonical transcripts (such as differentiation or tumor-testis antigens) or mutations (both driver and passenger mutations), recent results have shown that noncanonical transcripts...
4.
Born E, Lipskaia L, Breau M, Houssaini A, Beaulieu D, Marcos E, et al.
Circulation
. 2022 Dec;
147(8):650-666.
PMID: 36515093
Background: Senescent cells (SCs) are involved in proliferative disorders, but their role in pulmonary hypertension remains undefined. We investigated SCs in patients with pulmonary arterial hypertension and the role of...
5.
Freitas E, Nogueira M, Diaz A, Lomba E, Lefevre M, Alband N, et al.
Eur J Dermatol
. 2022 Oct;
32(4):555-556.
PMID: 36301771
No abstract available.
6.
Grout J, Sirven P, Leader A, Maskey S, Hector E, Puisieux I, et al.
Cancer Discov
. 2022 Aug;
12(11):2606-2625.
PMID: 36027053
Significance: The cellular and molecular programs driving T-cell marginalization in solid tumors remain unclear. Here, we describe two CAF populations associated with T-cell exclusion in human lung tumors. We demonstrate...
7.
Danila I, Alband N, Lomba E, Nogueira M, Lefevre M, Mohme S, et al.
Eur J Dermatol
. 2022 Jul;
32(2):290-293.
PMID: 35866922
No abstract available.
8.
Heran M, Renaud F, Louvet C, Piessen G, Voron T, Lefevre M, et al.
Dig Liver Dis
. 2022 Jul;
55(2):276-282.
PMID: 35780065
Background: The use of neoadjuvant chemotherapy (NAC) in patients with mismatch repair (MMR) deficient (dMMR) localized gastric and oeso-gastric junction (OGJ) adenocarcinoma is subject of debate. Histological response assessment might...
9.
Frosio F, Cervantes B, Nassar A, Faermark N, Sanou Y, Bonnet S, et al.
Langenbecks Arch Surg
. 2022 Mar;
407(5):1971-1980.
PMID: 35347398
Background: The number of lesions and the size of the largest (CRLMmax) have been widely investigated as prognostic factors in patients with colorectal liver metastases (CRLM). The aim of the...
10.
Watson S, Cyrta J, Lefevre M, Planchon J, Louvet C, Servois V, et al.
JCO Precis Oncol
. 2022 Jan;
5:370-377.
PMID: 34994599
No abstract available.